par-drugs-chemicals-ltd
Par Drugs & Chemicals Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|
Revenue | 35.67 | 22.68 | 22.77 |
Operating Expense | 23.25 | 18.37 | 16.73 |
Net Profit | 8.60 | 2.53 | 3.72 |
Net Profit Margin | 24.11 | 11.16 | 16.34 |
Earning Per Share | 6.99 | 2.06 | 3.02 |
EBIDTA | 12.43 | 4.30 | 6.01 |
Effective Tax Rate | 23.27 | 19.72 | 22.31 |
Particulars | Sep 2024 |
---|---|
Revenue | 35.67 |
Operating Expense | 23.25 |
Net Profit | 8.60 |
Net Profit Margin | 24.11 |
Earning Per Share | 6.99 |
EBIDTA | 12.43 |
Effective Tax Rate | 23.27 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Total Revenue Annual | 95.64 | 95.75 | 75.07 |
Operating Expenses Annual | 72.82 | 77.54 | 58.82 |
Operating Profit Annual | 23.06 | 18.45 | 16.44 |
Interest Annual | 0.11 | 0.13 | 0.45 |
Depreciation | 3.44 | 3.23 | 3.28 |
Net Profit Annual | 14.50 | 11.33 | 9.21 |
Tax Annual | 5.02 | 3.75 | 3.49 |
Particulars | Mar 2024 |
---|---|
Total Revenue Annual | 95.64 |
Operating Expenses Annual | 72.82 |
Operating Profit Annual | 23.06 |
Interest Annual | 0.11 |
Depreciation | 3.44 |
Net Profit Annual | 14.50 |
Tax Annual | 5.02 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Cash Flow at the Beginning | 22.24 | 16.21 | 21.16 |
Cash Flow from Operations | 20.25 | 13.38 | 7.62 |
Cash Flow from Investing | -5.84 | -7.34 | -3.02 |
Cash Flow from Financing | TBA | TBA | -9.55 |
Cash Flow at the End | 36.65 | 22.24 | 16.21 |
Particulars | Mar 2024 |
---|---|
Cash Flow at the Beginning | 22.24 |
Cash Flow from Operations | 20.25 |
Cash Flow from Investing | -5.84 |
Cash Flow from Financing | TBA |
Cash Flow at the End | 36.65 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
PBDIT Margin (%) | 24.11 | 19.26 | 19.36 |
PBIT Margin (%) | 20.51 | 15.89 | 15.50 |
PBT Margin (%) | -166.08 | -106.30 | -18.94 |
Net PROFIT Margin (%) | 15.16 | 11.83 | 10.85 |
Return On Networth / Equity (%) | 18.49 | 17.28 | 16.43 |
Return On Networth /Employed (%) | 25.01 | 23.11 | 21.70 |
Return On Assets (%) | 18.50 | 17.16 | 15.20 |
Total Debt / Equity (X) | TBA | TBA | 0.07 |
Asset Turnover Ratio (%) | 1.22 | 1.45 | 1.40 |
Particulars | Mar 2024 |
---|---|
PBDIT Margin (%) | 24.11 |
PBIT Margin (%) | 20.51 |
PBT Margin (%) | -166.08 |
Net PROFIT Margin (%) | 15.16 |
Return On Networth / Equity (%) | 18.49 |
Return On Networth /Employed (%) | 25.01 |
Return On Assets (%) | 18.50 |
Total Debt / Equity (X) | TBA |
Asset Turnover Ratio (%) | 1.22 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Fixed Assets Annual | 41.31 | 38.45 | 34.10 |
Total Current Assets Annual | 59.62 | 49.44 | 43.56 |
Non Current Assets Annual | 41.99 | 39.43 | 35.13 |
Total Shareholders Funds Annual | 85.63 | 71.24 | 59.88 |
Total Assets Annual | 101.61 | 88.87 | 78.69 |
Particulars | Mar 2024 |
---|---|
Fixed Assets Annual | 41.31 |
Total Current Assets Annual | 59.62 |
Non Current Assets Annual | 41.99 |
Total Shareholders Funds Annual | 85.63 |
Total Assets Annual | 101.61 |
No Data Availabe